Loading clinical trials...
Loading clinical trials...
This single center, multiple ascending dose study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of RO4905417 at different doses in healthy volunteers and patients with pe...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT05834673 · Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Heart Disease (CHD), and more
NCT02936622 · Peripheral Arterial Disease (PAD)
NCT05246410 · Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD)
NCT03174522 · Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM), and more
NCT04749732 · Peripheral Arterial Disease (PAD), Intermittent Claudication
Gainesville, Florida
Cincinnati, Ohio
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions